Related Experiment Video
Updated: May 15, 2026
High efficiency, Site-specific Transfection of Adherent Cells with siRNA Using Microelectrode Arrays (MEA)
Published on: September 13, 2012
mRNA electroporation as a tool for immunomonitoring.
Nathalie Cools1, Kirsten Van Camp, Viggo Van Tendeloo
1Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine & Health Sciences, University of Antwerp, Wilrijk, Belgium. Nathalie.Cools@uza.be
A new assay enables direct ex vivo analysis of multi-epitope antigen-specific immune responses using cryopreserved peripheral blood mononuclear cells (PBMC). This rapid method is convenient for monitoring cellular immune status in clinical vaccination trials.
Area of Science:
- Immunology
- Vaccinology
- Cellular Biology
Background:
- Immune response monitoring is crucial for evaluating vaccine efficacy in clinical trials.
- Peripheral blood mononuclear cells (PBMC) are often isolated and cryopreserved for later analysis.
- Current methods may not be optimal for timely assessment of cellular immune status.
Purpose of the Study:
- To develop a rapid, direct ex vivo assay for analyzing antigen-specific immune responses.
- To enable efficient monitoring of cellular immune status in patients undergoing vaccination.
- To utilize cryopreserved PBMC for immediate ex vivo analysis.
Main Methods:
- Development of a short-time assay for direct ex vivo analysis.
- Utilizing mRNA electroporation of cryopreserved PBMC.
- Analysis of multi-epitope antigen-specific immune responses.
Main Results:
- A novel, rapid assay for direct ex vivo immune response analysis was developed.
- The assay allows for the use of cryopreserved PBMC.
- The method facilitates the assessment of multi-epitope antigen-specific immune responses.
Conclusions:
- The newly developed assay is a rapid and elegant tool for immune monitoring.
- This method is convenient for assessing the cellular immune status of patients in clinical vaccination settings.
- Direct ex vivo analysis of cryopreserved PBMC offers a valuable approach for vaccine trial monitoring.
